“Evaluation of Thiol Disulfide, Ischemia Modified Albumin, and Prolidase Parameters in Patients With Localized Scleroderma”, Dermatol Pract Concept, vol. 14, no. 4, p. e2024249, Oct. 2024, doi: 10.5826/dpc.1404a249.